Plexus Corp.

NasdaqGS:PLXS Aktierapport

Börsvärde: US$7.3b

Plexus Framtida tillväxt

Future kriterier kontrolleras 1/6

Plexus förväntas öka intäkter och intäkter med 13.2% respektive 10.5% per år. EPS förväntas tillväxt med 13.7% per år. Avkastningen på eget kapital förväntas bli 13.4% om 3 år.

Viktig information

13.2%

Tillväxttakt i vinsten

13.70%

Tillväxttakt för EPS

Electronic vinsttillväxt24.3%
Intäkternas tillväxttakt10.5%
Framtida avkastning på eget kapital13.42%
Bevakning av analytiker

Low

Senast uppdaterad04 May 2026

Senaste uppdateringarna om framtida tillväxt

Recent updates

Ny analys • May 04

Semicap And Aerospace Slowdowns Will Pressure Margins And Constrain Future Cash Generation

Catalysts About Plexus Plexus provides design, engineering and manufacturing services for complex electronic products across aerospace and defense, healthcare, industrial and other end markets. What are the underlying business or industry changes driving this perspective?
Analysuppdatering • Apr 25

PLXS: Higher P/E And Rich Multiple Will Likely Cap Future Upside

Plexus' analyst fair value estimate has been adjusted from $200.80 to $210.80 as analysts factor in updated assumptions on growth, margins and future P/E, supported by a series of recent target increases and an upgrade from major research firms. Analyst Commentary Recent Street research on Plexus focuses on refreshed targets and an upgrade, which analysts link to their updated assumptions on growth, margins and the P/E they are willing to apply to the stock.
Analysuppdatering • Apr 10

PLXS: Higher P/E Assumptions Will Likely Limit Upside Despite Buybacks

Analysts have raised their price targets on Plexus from $25 to $50, citing updated assumptions around discount rates and future P/E ratios that support a refined view of the stock's valuation. Analyst Commentary Recent research updates on Plexus focus heavily on how revised discount rates and updated P/E assumptions shape the new price targets.
Analysuppdatering • Mar 27

PLXS: Raised Price Views And Buybacks Will Likely Support Balanced Trading Outlook

Analysts have raised their Plexus price targets by $25 to $50, pointing to modestly adjusted assumptions for growth, margins, and future P/E to support their higher valuation views. Analyst Commentary Recent research points to a cluster of higher Plexus price targets in the US$25 to US$50 range above prior levels, reflecting tweaked assumptions around growth, margins, and the P/E multiple investors might be willing to pay.
Analysuppdatering • Mar 12

PLXS: Updated Earnings Views And Buybacks Will Likely Support Balanced Trading Outlook

Analysts have raised their average Plexus price target by a combined $105. This reflects updated assumptions on discount rates, revenue growth, profit margins and future P/E multiples.
Analysuppdatering • Feb 26

PLXS: Higher Earnings Assumptions And Buybacks May Sustain Sideways Trading

Narrative Update on Plexus The analysts’ average price target for Plexus has increased by a combined $105 in recent reports, reflecting updated assumptions for discount rates, revenue growth, profit margins, and a slightly lower future P/E multiple. Analyst Commentary Recent Street research on Plexus centers on higher price targets, with analysts updating their models around discount rates, revenue expectations, margin assumptions, and a slightly lower future P/E multiple.
Analysuppdatering • Feb 09

PLXS: Higher Earnings Assumptions May Support Sideways Trading Near Current Range

The analyst price target for Plexus has shifted from US$159 to about US$201, as analysts factor in updated views on revenue growth, profit margins, and the P/E multiple they are comfortable assigning to the stock. Analyst Commentary Bullish analysts have increased their price targets in several steps, including US$25, US$30, and US$50 adjustments, which lines up with the higher overall target of about US$201.
Ny analys • Jan 31

Aerospace And Defense Outsourcing Wave Will Support Stronger Long Term Outlook

Catalysts About Plexus Plexus provides outsourced design, engineering and manufacturing solutions for complex products across Healthcare, Industrial and Aerospace and Defense end markets. What are the underlying business or industry changes driving this perspective?
Analysuppdatering • Jan 26

PLXS: Manufacturing Partnership And Stable Outlook Will Likely Support Sideways Trading

Analysts have maintained their Plexus fair value estimate at $159.00. The updated assumptions reflect slightly adjusted revenue growth, revised profit margin expectations, and a marginally higher future P/E multiple as they refine their price target framework.
Analysuppdatering • Jan 12

PLXS: Robust Finish And New Partnership Will Likely Support Sideways Trading

Analysts have raised their Plexus price target to $150 from $140, citing solid recent results and consistent execution. They also noted a more cautious stance on longer term estimates given the current macro backdrop.
Analysartikel • Dec 30

Is It Too Late To Consider Buying Plexus Corp. (NASDAQ:PLXS)?

Plexus Corp. ( NASDAQ:PLXS ), is not the largest company out there, but it saw a double-digit share price rise of over...
Analysuppdatering • Dec 24

PLXS: Shares Will Likely Trade Sideways As Robust Finish Meets Rich Pricing

Analysts have nudged their Plexus price target higher to $150 from $140, citing a robust fiscal year finish that beat sales and earnings expectations while still acknowledging valuation and macroeconomic uncertainties. Analyst Commentary Street research on Plexus reflects a mix of optimism around recent execution and caution regarding valuation and the macro backdrop, leading to a more balanced risk reward profile at current levels.
Analysuppdatering • Dec 10

PLXS: Shares Will Likely Trade Steadily As Execution Offsets Macro Caution

Analysts have modestly increased their Plexus price target to approximately $159 per share. This reflects confidence in the company’s robust execution and long term growth prospects, despite a more cautious stance on the macro environment and valuation.
Analysuppdatering • Nov 26

PLXS: Shares Will Likely Climb With Confidence In Earnings Momentum

Analysts have modestly increased Plexus’s average price target, citing robust recent results, a positive management outlook, and continued confidence in the company’s growth prospects, with new targets ranging up to $165 from previous levels around $140 to $160. Analyst Commentary Following the latest quarterly report, analysts have provided updated perspectives on Plexus, balancing improved outlooks with some caution regarding future risks.
Analysuppdatering • Nov 09

PLXS: Shares Will Likely Reflect Mixed Views As Macro Uncertainty Persists

Analysts have slightly raised their price targets for Plexus, citing strong recent results and ongoing confidence in the company's growth prospects. The new targets range from $150 to $165, which is an increase of $10 to $5 from previous estimates.
Analysuppdatering • Oct 26

Execution On Expansion Plans Will Shape Near-Term Manufacturing Opportunities

The analyst consensus price target for Plexus has increased by $4.40 to $159.00. This reflects upward revisions in revenue growth expectations and ongoing confidence in management’s execution, even as some firms have issued cautious outlooks recently.
Seeking Alpha • Sep 11

Plexus: Pipeline Underscores The Growth Potential Amid Short-Term Headwinds

Summary Plexus delivers steady execution and stable margins, but faces uneven growth and slower program ramps compared to AI-focused peers. Revenue and earnings growth are projected to be modest, with recovery in industrial and healthcare end markets critical for upside. Valuation remains reasonable, trading near historical P/E, but lacks catalysts to drive a bullish re-rating in the near term. With limited near-term upside and risks from slow program execution, I maintain a neutral stance on Plexus shares. Read the full article on Seeking Alpha
Analysartikel • Sep 11

Return Trends At Plexus (NASDAQ:PLXS) Aren't Appealing

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
Analysartikel • Jun 24

Why Investors Shouldn't Be Surprised By Plexus Corp.'s (NASDAQ:PLXS) P/E

Plexus Corp.'s ( NASDAQ:PLXS ) price-to-earnings (or "P/E") ratio of 25.4x might make it look like a sell right now...
Analysartikel • May 24

Should You Investigate Plexus Corp. (NASDAQ:PLXS) At US$130?

While Plexus Corp. ( NASDAQ:PLXS ) might not have the largest market cap around , it saw a double-digit share price...
Seeking Alpha • Sep 16

Plexus Is Overvalued Despite Its Unique Position In Manufacturing

Summary Plexus has a distinct position in the manufacturing market for low-to-mid volume in specialized industries with high regulatory requirements, like healthcare and defense. This provides somewhat of a moat. Despite this strength, the stock is currently overvalued based on my peer and company-specific historical valuation analysis. I expect its P/E non-GAAP ratio will contract. In an optimistic scenario, there is the potential for a 12-month return of 20%+. However, this depends on EPS up revisions continuing and a moderate contraction in its P/E ratio. Even in the event of a strong 12-month return, the long-term thesis is weaker due to lower fundamental growth estimates for FY26 against FY25. Read the full article on Seeking Alpha
User avatar
Ny analys • Sep 04

Aerospace And Healthcare Drive Growth Amid Rising Efficiency And Responsible Practices

Expected revenue growth driven by strong demand in Aerospace, Healthcare/Life Sciences, and semiconductor sectors, enhancing future earnings.

Prognoser för vinst- och omsättningstillväxt

NasdaqGS:PLXS - Analytikernas framtida uppskattningar och tidigare finansiella data (USD Millions )
DatumIntäkterIntäkterFritt kassaflödeKassaflöde från rörelsenGenomsnittligt Antal analytiker
9/30/20285,443265N/A2521
9/30/20275,2152241962555
9/30/20264,722191461615
4/4/20264,31018876172N/A
1/3/20264,12717776180N/A
9/27/20254,033173154249N/A
6/28/20254,025163251337N/A
3/29/20253,968143352442N/A
12/28/20243,954120400493N/A
9/28/20243,961112341437N/A
6/29/20243,934111213306N/A
3/30/20243,99510287193N/A
12/30/20234,099126102212N/A
9/30/20234,21013962166N/A
7/1/20234,310149-2176N/A
4/1/20234,270171-5136N/A
12/31/20224,088157-7814N/A
10/1/20223,811138-128-26N/A
7/2/20223,531121-123-15N/A
4/2/20223,364111-4949N/A
1/1/20223,356126-2847N/A
10/2/20213,36913985143N/A
7/3/20213,439143206249N/A
4/3/20213,482152211254N/A
1/2/20213,36812390142N/A
10/3/20203,390117160210N/A
7/4/20203,287117144201N/A
4/4/20203,230106129195N/A
1/4/20203,251117N/A223N/A
9/28/20193,164109N/A115N/A
6/29/20193,125145N/A32N/A
3/30/20193,052146N/A29N/A
12/29/20182,962134N/A-36N/A
9/29/20182,87413N/A67N/A
6/30/20182,772-31N/A91N/A
3/31/20182,665-32N/A69N/A
12/30/20172,570-15N/A161N/A
9/30/20172,528112N/A172N/A
7/1/20172,511102N/A127N/A
4/1/20172,560103N/A142N/A
12/31/20162,57490N/A186N/A
10/1/20162,55676N/A128N/A
7/2/20162,57281N/A144N/A
4/2/20162,57479N/A127N/A
1/2/20162,60686N/A188N/A
10/3/20152,65494N/A77N/A
7/4/20152,65297N/A86N/A

Analytiker Framtid Tillväxt Prognoser

Intäkter kontra sparande: PLXS s prognostiserade vinsttillväxt ( 13.2% per år) är över sparkvoten ( 3.5% ).

Resultat vs marknad: PLXS s intäkter ( 13.2% per år) förväntas växa långsammare än marknaden för US ( 16.8% per år).

Höga tillväxtresultat: PLXS s intäkter förväntas växa, men inte avsevärt.

Intäkt vs marknad: PLXS s intäkter ( 10.5% per år) förväntas växa långsammare än marknaden för US ( 11.6% per år).

Hög tillväxtintäkter: PLXS s intäkter ( 10.5% per år) förväntas växa långsammare än 20% per år.

Tillväxtprognoser för vinst per aktie

Framtida avkastning på eget kapital

Framtida ROE: PLXS s avkastning på eget kapital förväntas bli låg om 3 år ( 13.4 %).

Upptäck tillväxtföretag

7D

1Y

7D

1Y

7D

1Y

Företagsanalys och finansiella data Status

UppgifterSenast uppdaterad (UTC-tid)
Analys av företag2026/05/12 04:03
Aktiekurs vid dagens slut2026/05/12 00:00
Intäkter2026/04/04
Årlig intjäning2025/09/27

Datakällor

Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.

PaketUppgifterTidsramExempel US-källa
Företagets finansiella ställning10 år
  • Resultaträkning
  • Kassaflödesanalys
  • Balansräkning
Analytikernas konsensusuppskattningar+3 år
  • Prognos för finansiella poster
  • Analytikernas prismål
Marknadspriser30 år
  • Aktiekurser
  • Utdelningar, splittar och åtgärder
Ägarskap10 år
  • Största aktieägare
  • Insiderhandel
Förvaltning10 år
  • Ledningsgrupp
  • Styrelse och verkställande direktörer
Viktiga utvecklingstendenser10 år
  • Företagsmeddelanden

* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.

Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.

Analysmodell och snöflinga

Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.

Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.

Industri- och sektormått

Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.

Källor för analytiker

Plexus Corp. bevakas av 15 analytiker. 5 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.

AnalytikerInstitution
Reik ReadBaird
Wamsi MohanBofA Global Research
Andrew HuangB. Riley Securities, Inc.